Satoshi Wada

15PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 15, 2026
Association of Prior Local Therapy with Outcomes Within Systemic Therapy Regimen Cohorts in Advanced Soft Tissue Sarcoma: A Retrospective Cohort Study.

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|May 13, 2026
Single-Dose Toxicity Study of Self-Assembling A6K/Sodium Borocaptate (BSH) Peptide Nanotubes as a New Boron Delivery Agent for Boron Neutron Capture Therapy (BNCT) in Mice.

|Dec 30, 2025
Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study.

Risako Suzuki, Ryotaro Ohkuma, Makoto Watanabe

|Jul 29, 2025
Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study.

Makoto Watanabe, Katsuaki Ieguchi, Takashi Shimizu

|Jan 23, 2024
Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit.

Masahiro Hosonuma, Yuya Hirasawa, Atsuo Kuramasu

Pageof 3

Frequent Collaborators

5 joint publications

Takuya Tsunoda

4 joint publications

Ryotaro Ohkuma

3 joint publications

Atsushi Horiike

3 joint publications

Masahiro Shimokawa